Mediterr J Rheumatol 2017;28(3):157-60
Clinical Utility of MBDA Panel in the Management of Adult Onset Still’s Disease
Authors Information

1: Internal Medicine Department, Mount Sinai Beth Israel Medical Center, New York, NY, USA

2: NYU Langone School of Medicine, New York, NY, USA

  1. Aleksandrova E N, Novikov A A, Nasonov E L. The role of biomarkers in diagnostics and forecasting of effectiveness of modern therapy of rheumatoid arthritis. Klin Lab Diagn. 2013;3-13. PubMed PMID: 24340741.
  2. Bywaters E G. Still's disease in the adult. Ann Rheum Dis 1971;30:121-33. PubMed PMID: 5315135. Pubmed Central PMCID: 1005739.
  3. Gopalarathinam R, Orlowsky E, Kesavalu R, Yelaminchili S. Adult Onset Still's Disease: A Review on Diagnostic Workup and Treatment Options. Case Rep Rheumatology 2016;2016:6502373. PubMed PMID: 27042373. Pubmed Central PMCID: 4794578.
  4. Kadavath S, Efthimiou P. Adult-onset Still's disease-pathogenesis, clinical manifestations, and new treatment options. Ann Med 2015;47:6-14. PubMed PMID: 25613167.
  5. Curtis J R, van der Helm-van Mil A H, Knevel R, Huizinga T W, Haney D J, Shen Y, et al. Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity. Arthritis Care Res 2012;64:1794-803. PubMed PMID: 22736476. Pubmed Central PMCID: 3508159.
  6. Segurado O G, Sasso E H. Vectra DA for the objective measurement of disease activity in patients with rheumatoid arthritis. Clin Exp Rheumatol 2014;32:S29-34. PubMed PMID: 25365086.
  7. Wu T, Sajitharan D, Mohan C. Biomarkers of rheumatoid arthritis: recent progress. Expert Opin Med Diagn 2010;4:293-305. PubMed PMID: 23496146.